CANNAPHARMARX, INC. Conversion Gains and Losses on Foreign Investments
CANNAPHARMARX, INC. (CPMD) reported Conversion Gains and Losses on Foreign Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ConversionGainsAndLossesOnForeignInvestments · last filed 2026-03-31
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for the quarter ending 2025-12-31 was $0.00.
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for the quarter ending 2025-09-30 was $0.00.
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for the quarter ending 2025-03-31 was $0.00.
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CANNAPHARMARX, INC. conversion gains and losses on foreign investments for fiscal 2024 was $690.71K.
| Period end | Conversion Gains and Losses on Foreign Investments 3 month | Conversion Gains and Losses on Foreign Investments 6 month | Conversion Gains and Losses on Foreign Investments 9 month | Conversion Gains and Losses on Foreign Investments 12 month | Conversion Gains and Losses on Foreign Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $1.37M derived: sum of 4 quarters · filed 2026-03-31 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $1.37M derived: sum of 3 quarters · filed 2026-03-31 | $690.71K 10-K · filed 2026-03-31 | $67.44K 10-Q · filed 2025-05-16 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $1.37M derived: sum of 2 quarters · filed 2025-11-14 | $690.71K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $1.37M 10-Q · filed 2025-08-14 | $690.71K 10-Q · filed 2025-08-14 |